Please try another search
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Name | Age | Since | Title |
---|---|---|---|
Robert Andrew Eckert | 62 | 2023 | Lead Independent Director |
Peter M. Neupert | 68 | 2023 | Independent Director |
David Ross Smith | 58 | 2023 | Independent Director |
Thomas H. Pike | 65 | - | CEO, President & Chairman |
Amrit Ray | 50 | 2023 | Independent Director |
Edward A. Pesicka | 56 | 2023 | Independent Director |
A. Machelle Sanders | 60 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review